Auf dieser Seite
EHC Encompass Health Corporation Common Stock
NYSE · Health Care · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 7, 2026
$119,80
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$92,7752-Wochen-Tief
$127,9952-Wochen-Hoch
Marktkapitalisierung (MRQ)
$11.84B
P/E (TTM)
19.5
EPS (TTM)
$6.14
Umsatz (TTM)
$6.21B
Ihre Abzeichen
52W-Spanne
$93–$128
Analystenbewertung
BUY
Kursziel
$148
P/E
19.5
ROE
25.5%
Nettogewinnmarge
10.0%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
EHC Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$119.80
Marktkapitalisierung (MRQ)
$11.84B
P/E (TTM)
19.5
EPS (TTM)
$6.14
Umsatz (TTM)
$6.21B
Dividendenrendite
0.60%
ROE (TTM)
25.5%
52W-Spanne
$93–$128
EHC Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 1. Juli 2022 | 1257-for-1000 | Vorwärts |
| 26. Oktober 2006 | 1-for-5 | Umgekehrt |
| 18. März 1997 | 2-for-1 | Vorwärts |
| 18. April 1995 | 2-for-1 | Vorwärts |
| 2. Januar 1992 | 3-for-2 | Vorwärts |
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$5.94B2016-12-31 → 2025-12-31
EPS$5.542016-12-31 → 2025-12-31
Freier Cashflow$439M2016-12-31 → 2025-12-31
Nettogewinnmarge10.0%2018-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | EHC | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | 19.55-Jahres-Durchschnitt ≈18.8 | ≈18.8 | 16.5 | Fairer Wert | |
| P/S (TTM) | 1.95-Jahres-Durchschnitt ≈1.5 | ≈1.5 | 1.3 | Überbewertet | |
| K/B (MRQ) | 4.65-Jahres-Durchschnitt ≈4.0 | ≈4.0 | 3.8 | Überbewertet | |
| Kurs / FCF (TTM) | 28.65-Jahres-Durchschnitt ≈29.0 | ≈29.0 | · | · | |
| Kurs / Cashflow (TTM) | 9.85-Jahres-Durchschnitt ≈8.4 | ≈8.4 | 9.7 | Unterbewertet | |
| Kurs / Materieller Buchwert (MRQ) | 5.25-Jahres-Durchschnitt ≈29.6 | ≈29.6 | · | · | |
| PEG Ratio (PEG-Ratio) | ≈1.4 | · | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | EHC | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| EBITDA Margin (EBITDA-Marge) | 5.5%5-Jahres-Durchschnitt ≈8.0% | ≈8.0% | 11.1% | Schwach | |
| Vorgewinnmarge (TTM) | 16.6%5-Jahres-Durchschnitt ≈13.2% | ≈13.2% | 9.8% | Spitzenklasse | |
| Nettogewinnmarge (TTM) | 10.0%5-Jahres-Durchschnitt ≈7.9% | ≈7.9% | 7.3% | Spitzenklasse | |
| ROA (TTM) | 8.7%5-Jahres-Durchschnitt ≈6.4% | ≈6.4% | 6.5% | Spitzenklasse | |
| ROE (TTM) | 25.5%5-Jahres-Durchschnitt ≈22.8% | ≈22.8% | 19.1% | Spitzenklasse |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | EHC | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 1.25-Jahres-Durchschnitt ≈1.2 | ≈1.2 | 1.2 | Im Einklang | |
| Quick Ratio | 0.85-Jahres-Durchschnitt ≈0.9 | ≈0.9 | 0.9 | Im Einklang |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | EHC | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 10.5%5-Jahres-Durchschnitt ≈10.7% | ≈10.7% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 10.9%5-Jahres-Durchschnitt ≈10.5% | ≈10.5% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 10.7% | · | · | · | |
| EPS YoY (EPS VjV) | 24.2%5-Jahres-Durchschnitt ≈18.2% | ≈18.2% | · | · | |
| Net Income YoY (Nettogewinn YoY) | 24.2%5-Jahres-Durchschnitt ≈18.9% | ≈18.9% | · | · | |
| EPS CAGR 3Y (EPS CAGR 3J) | 27.1%5-Jahres-Durchschnitt ≈12.2% | ≈12.2% | · | · | |
| EPS CAGR 5Y (EPS CAGR 5J) | 14.2% | · | · | · | |
| Net Income CAGR 3Y (Nettoergebnis CAGR 3J) | 27.8%5-Jahres-Durchschnitt ≈12.9% | ≈12.9% | · | · | |
| Net Income CAGR 5Y (Nettoergebnis CAGR 5J) | 14.8% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | EHC | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.95-Jahres-Durchschnitt ≈0.8 | ≈0.8 | 0.8 | Im Einklang | |
| Receivables Turnover (Forderungsumschlag) | 9.85-Jahres-Durchschnitt ≈8.8 | ≈8.8 | 8.4 | Spitzenklasse | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$199.8K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR
Dividendenrendite0.60%
Ausschüttungsquote12.6%
Annualisierte Auszahlung≈$0.76
5J Div CAGR≈-5.3%
Wachstumsphase≈1
| Ex-Datum | Betrag | Währung | Rendite |
|---|---|---|---|
| Jul 1, 2026 | $0,19 | USD | ≈0.75% |
| Apr 1, 2026 | $0,19 | USD | ≈0.76% |
| Jan 2, 2026 | $0,19 | USD | ≈0.68% |
| Okt 1, 2025 | $0,19 | USD | ≈0.56% |
| Jul 1, 2025 | $0,17 | USD | ≈0.56% |
| Apr 1, 2025 | $0,17 | USD | ≈0.65% |
| Jan 2, 2025 | $0,17 | USD | ≈0.70% |
| Okt 1, 2024 | $0,17 | USD | ≈0.65% |
| Jul 1, 2024 | $0,15 | USD | ≈0.70% |
| Mär 28, 2024 | $0,15 | USD | ≈0.73% |
| Dez 29, 2023 | $0,15 | USD | ≈0.90% |
| Sep 29, 2023 | $0,15 | USD | ≈0.89% |
| Jun 30, 2023 | $0,15 | USD | ≈1.3% |
| Mär 31, 2023 | $0,15 | USD | ≈1.3% |
| Dez 30, 2022 | $0,15 | USD | ≈1.3% |
| Sep 30, 2022 | $0,15 | USD | ≈1.9% |
| Jul 12, 2022 | $0,28 | USD | ≈2.0% |
| Mär 31, 2022 | $0,22 | USD | ≈1.6% |
| Dez 31, 2021 | $0,22 | USD | ≈1.7% |
| Sep 30, 2021 | $0,22 | USD | ≈1.5% |
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
8.6%
Nächster Bericht
Okt 27, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 3, 2026 | $1.55 | $1.49 | 3.7% |
| 31. März 2026 | $1.60 | $1.51 | 5.8% | |
| 31. Dezember 2025 | $1.46 | $1.31 | 11.3% | |
| 30. September 2025 | $1.23 | $1.21 | 1.9% | |
| 30. Juni 2025 | $1.40 | $1.22 | 14.6% | |
| 31. März 2025 | $1.37 | $1.20 | 14.1% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.94B | $5.37B | $4.80B | $4.35B | $4.01B | $3.57B | $4.61B | $4.28B | $3.91B | $3.64B | |
| SG&A Expense | $236M | $209M | $202M | $154M | $170M | $152M | $247M | $220M | $172M | $133M | |
| Operating Expenses | $4.88B | $4.51B | $4.07B | $3.72B | $3.36B | $3.04B | $3.91B | $3.65B | $3.26B | $2.99B | |
| Operating Income | · | · | · | $540M | $560M | $564M | $612M | $555M | $578M | $588M | |
| Interest Expense | · | · | $144M | $176M | $164M | $184M | $160M | $147M | $154M | $172M | |
| Other Non-op | $19M | $20M | $16M | $-5M | $8M | $8M | $30M | $2M | $4M | $3M | |
| Pretax Income | $953M | $750M | $607M | $451M | $505M | $353M | $562M | $493M | $496M | $482M | |
| Income Tax | $193M | $150M | $132M | $100M | $102M | $75M | $116M | $119M | $146M | $164M | |
| Net Income | $566M | $456M | $352M | $271M | $412M | $284M | $359M | $292M | $271M | $248M | |
| EPS (Basic) | $5.62 | $4.53 | $3.51 | $2.72 | $4.15 | $2.87 | $3.65 | $2.98 | $2.88 | $2.77 | |
| EPS (Diluted) | $5.54 | $4.46 | $3.47 | $2.70 | $4.11 | $2.85 | $3.61 | $2.93 | $2.84 | $2.59 | |
| Shares (Basic) | 100,500,000 | 99,900,000 | 99,500,000 | 99,200,000 | 99,000,000 | 98,600,000 | 98,000,000 | 97,900,000 | 93,700,000 | 89,100,000 | |
| Shares (Diluted) | 102,200,000 | 102,200,000 | 101,300,000 | 100,400,000 | 100,200,000 | 99,800,000 | 99,400,000 | 99,800,000 | 99,300,000 | 99,500,000 | |
| EBITDA | $328M | $300M | $274M | $783M | $257M | $807M | $831M | $755M | $762M | $761M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $72M | $85M | $69M | $22M | $49M | $186M | $60M | $69M | $54M | $40M | |
| Receivables | $619M | $593M | $600M | $525M | $502M | $563M | $499M | $460M | $460M | $432M | |
| Prepaid Expense | $54M | $42M | $34M | $35M | $115M | $86M | $98M | $66M | $113M | $109M | |
| Other Current Assets | $184M | $123M | $92M | $92M | $115M | $86M | $98M | $66M | $113M | $170M | |
| Current Assets | $906M | $887M | $842M | $717M | $921M | $949M | $756M | $662M | $702M | $654M | |
| PP&E (Net) | · | · | · | · | · | · | $1.96B | $1.63B | $1.52B | $1.39B | |
| PP&E (Gross) | · | · | · | · | · | · | · | $2.63B | $2.45B | $2.28B | |
| Goodwill | $1.32B | $1.28B | $1.28B | $1.26B | $1.24B | $1.23B | $1.22B | $2.10B | $1.97B | $1.93B | |
| Intangibles | $308M | $298M | $278M | $282M | $158M | $431M | $476M | $443M | $403M | $411M | |
| Other Non-current Assets | $244M | $219M | $192M | $222M | $230M | $295M | $305M | $291M | $235M | $221M | |
| Total Assets | $7.09B | $6.53B | $6.10B | $5.64B | $6.86B | $6.45B | $6.08B | $5.17B | $4.86B | $4.68B | |
| Accounts Payable | $178M | $171M | $170M | $133M | $134M | $115M | $95M | $90M | $78M | $68M | |
| Accrued Liabilities | $55M | $31M | · | · | · | · | · | · | · | · | |
| Current Liabilities | $836M | $841M | $656M | $576M | $749M | $717M | $721M | $672M | $518M | $476M | |
| Capital Leases | $197M | $190M | $196M | $200M | $180M | $210M | $244M | $0 | · | · | |
| Deferred Tax | $127M | $105M | $87M | $83M | $23M | $52M | $0 | · | · | · | |
| Other Non-current Liabilities | $207M | $52M | $46M | $46M | $49M | $94M | $43M | $86M | $75M | $50M | |
| Total Liabilities | $3.81B | $3.69B | $3.81B | $3.77B | $4.47B | $4.44B | $4.15B | $3.36B | $3.25B | $3.61B | |
| Common Stock | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Paid-in Capital | $1.87B | $1.85B | $1.79B | $1.73B | $2.29B | $2.33B | $2.37B | $2.59B | $2.75B | $2.80B | |
| Retained Earnings | $1.29B | $797M | $406M | $116M | $142M | $-242M | $-526M | $-885M | $-1.18B | $-1.45B | |
| Treasury Stock | $722M | $578M | $547M | $537M | $521M | $497M | $492M | $428M | $418M | $615M | |
| AOCI | $500.0K | $0 | · | · | · | · | · | $0 | $-1M | $-1M | |
| Stockholders' Equity | $2.44B | $2.07B | $1.65B | $1.31B | $1.91B | $1.59B | $1.35B | $1.28B | $1.15B | $736M | |
| Liabilities + Equity | $7.09B | $6.53B | $6.10B | $5.64B | $6.86B | $6.45B | $6.08B | $5.17B | $4.86B | $4.68B | |
| Shares Outstanding | 100,000,000 | 100,800,000 | 100,300,000 | 99,800,000 | 99,500,000 | 99,400,000 | 98,600,000 | 98,900,000 | 98,300,000 | 88,900,000 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $328M | $300M | $274M | $244M | $220M | $203M | $219M | $200M | $184M | $173M | |
| Stock-based Comp | $56M | $48M | $51M | $29M | $29M | $26M | $114M | $86M | $48M | $27M | |
| Deferred Tax | $22M | $11M | $4M | $28M | $17M | $34M | $40M | $-9M | $61M | $133M | |
| Amort. of Intangibles | $28M | $29M | $32M | $29M | $31M | $33M | $58M | $51M | $49M | $48M | |
| Other Non-cash | $203M | $188M | $170M | $134M | $-14M | $96M | $-96M | $194M | $94M | $25M | |
| Operating Cash Flow | $1.18B | $1.00B | $851M | $706M | $716M | $705M | $635M | $762M | $658M | $640M | |
| CapEx | $736M | $642M | $583M | $584M | $546M | $393M | $372M | $254M | $226M | $178M | |
| Investing Cash Flow | $-765M | $-653M | $-603M | $-627M | $-666M | $-408M | $-657M | $-424M | $-283M | $-230M | |
| Net Debt Issued | · | · | · | · | · | · | $-520M | $-21M | $-130M | $-202M | |
| Stock Repurchased | $158M | $31M | $0 | $0 | $0 | $6M | $46M | $0 | $38M | $66M | |
| Net Stock Activity | $-158M | $-31M | · | $0 | $0 | $-6M | $-46M | $0 | $-38M | $-66M | |
| Dividends Paid | $71M | $63M | $60M | $99M | $112M | $112M | $109M | $101M | $92M | $84M | |
| Financing Cash Flow | $-431M | $-331M | $-197M | $-146M | $-240M | $-146M | $48M | $-321M | $-360M | $-416M | |
| Net Change in Cash | $-20M | $19M | $51M | $-67M | $-191M | $151M | $26M | $17M | $15M | $-6M | |
| Taxes Paid | $124M | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $439M | $360M | $268M | $141M | $187M | $309M | $263M | $508M | $431M | $428M | |
| Levered FCF | · | · | $155M | $4M | $57M | $165M | $136M | $396M | $327M | $314M |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | 12.4% | · | 12.1% | 13.3% | 13.0% | · | · | |
| Net Margin | 9.5% | 8.5% | 7.3% | 6.2% | 8.1% | 6.1% | 7.8% | 6.8% | · | · | |
| Pretax Margin | 16.1% | 14.0% | 12.7% | 10.4% | 12.8% | 10.2% | 12.2% | 11.5% | · | · | |
| EBITDA Margin | 5.5% | 5.6% | 5.7% | 18.0% | 5.0% | 17.4% | 18.0% | 17.6% | · | · | |
| ROA | 8.3% | 7.2% | 6.0% | 4.3% | 6.2% | 4.5% | 6.4% | 5.8% | 5.3% | 5.3% | |
| ROE | 25.1% | 24.5% | 23.8% | 16.8% | 23.6% | 19.3% | 27.3% | 24.1% | 26.7% | 36.8% | |
| ROIC | · | · | · | 32.0% | · | 27.7% | 35.9% | 33.0% | 33.1% | 52.7% |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.1 | 1.3 | 1.2 | 1.2 | 1.3 | 1.0 | 1.0 | 1.4 | 1.4 | |
| Quick Ratio | 0.8 | 0.8 | 1.0 | 0.9 | 1.0 | 1.1 | 0.8 | 0.8 | 1.0 | 1.0 | |
| Interest Coverage | · | · | · | 3.1 | · | 3.1 | 3.8 | 3.8 | 3.7 | 3.4 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.9 | 0.9 | 0.8 | 0.7 | 0.8 | 0.7 | 0.8 | 0.9 | · | · | |
| Receivables Turnover | 9.8 | 9.0 | 8.5 | 8.5 | 8.3 | 8.7 | 9.6 | 9.3 | · | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $24.38 | $20.51 | $16.43 | $13.13 | $19.21 | $15.98 | $13.71 | $12.91 | $12.02 | $8.28 | |
| Revenue / Share | $58.07 | $52.58 | $47.40 | $43.31 | $51.11 | $46.54 | $46.33 | $42.86 | · | · | |
| Cash Flow / Share | $11.50 | $9.81 | $8.40 | $7.03 | $7.14 | $7.06 | $6.39 | $7.64 | $6.62 | $6.09 | |
| Cash / Share | $0.72 | $0.85 | $0.69 | $0.22 | $0.55 | $2.25 | $0.96 | $0.70 | $0.55 | $0.46 | |
| Dividend / Share | $0.72 | $0.64 | $0.60 | $0.86 | $1.12 | $1.12 | $1.10 | $1.04 | $0.98 | $0.94 | |
| EPS (TTM) | $5.54 | $4.46 | $3.47 | $2.70 | $4.11 | $2.85 | $3.61 | $2.93 | $2.84 | $2.59 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 10.5% | 11.9% | 10.4% | 8.3% | 12.6% | · | · | · | · | · | |
| Revenue CAGR 3Y | 10.9% | 10.2% | 10.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 10.7% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 24.2% | 28.5% | 28.5% | -34.3% | 44.2% | · | · | · | · | · | |
| EPS CAGR 3Y | 27.1% | 2.8% | 6.8% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 14.2% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 24.2% | 29.5% | 29.9% | -34.3% | 45.0% | · | · | · | · | · | |
| Net Income CAGR 3Y | 27.8% | 3.4% | 7.4% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 14.8% | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | -8.6% | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $5.94B | $5.37B | $4.80B | $4.35B | $4.01B | $3.57B | $4.61B | $4.28B | $3.91B | $3.64B | |
| Net Income TTM | $566M | $456M | $352M | $271M | $412M | $284M | $359M | $292M | $271M | $248M | |
| Market Cap | $10.61B | $9.31B | $6.69B | $5.97B | $5.17B | $6.54B | $5.43B | $4.85B | $3.86B | $2.92B | |
| P/E | 19.2 | 20.7 | 19.2 | 22.2 | 12.6 | 23.1 | 15.3 | 16.8 | 13.8 | 12.7 | |
| P/S | 1.8 | 1.7 | 1.4 | 1.4 | 1.3 | 1.8 | 1.2 | 1.1 | 1.0 | 0.8 | |
| P/B | 4.4 | 4.5 | 4.1 | 4.6 | 2.7 | 4.1 | 4.0 | 3.8 | 3.3 | 4.0 | |
| P / Tangible Book | 13.1 | 19.2 | 76.0 | · | 10.0 | · | · | · | · | · | |
| P / Cash Flow | 9.0 | 9.3 | 7.9 | 8.5 | 7.2 | 9.3 | 8.6 | 6.4 | 5.9 | 4.8 | |
| P / FCF | 24.2 | 25.8 | 25.0 | 42.3 | 27.6 | 21.2 | 20.7 | 9.6 | 9.0 | 6.8 | |
| Dividend Yield | 0.67% | 0.67% | 0.90% | 1.7% | 2.2% | 1.7% | 2.0% | 2.1% | 2.4% | 2.9% | |
| Earnings Yield | 5.2% | 4.8% | 5.2% | 4.5% | 7.9% | 4.3% | 6.6% | 6.0% | 7.2% | 7.9% | |
| Payout Ratio | 12.6% | 13.8% | 17.2% | 36.5% | 27.3% | 39.4% | 30.3% | 34.5% | 35.7% | 33.8% | |
| Annual Payout | $71M | $63M | $60M | $99M | $112M | $112M | $109M | $101M | $92M | $84M |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.60B | $1.59B | $1.54B | $1.48B | $1.46B | $1.46B | $1.41B | $1.35B | $1.30B | $1.32B | $1.25B | $1.21B | $1.19B | $1.16B | $1.14B | $1.09B | |
| SG&A Expense | $63M | $58M | $68M | $56M | $59M | $52M | $54M | $54M | $50M | $50M | $53M | $50M | $55M | $43M | $43M | $38M | |
| Operating Expenses | $1.31B | $1.28B | $1.26B | $1.23B | $1.20B | $1.19B | $1.17B | $1.14B | $1.09B | $1.11B | $1.06B | $1.03B | $1.00B | $982M | $958M | $941M | |
| Operating Income | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $152M | $128M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $35M | · | $36M | $36M | $36M | · | $38M | |
| Other Non-op | $9M | $19M | $4M | $6M | $7M | $2M | $2M | $9M | $3M | $5M | $9M | $500.0K | $3M | $4M | $8M | $-4M | |
| Pretax Income | $262M | $289M | $258M | $220M | $237M | $239M | $201M | $184M | $186M | $178M | $165M | $145M | $151M | $146M | $151M | $107M | |
| Income Tax | $54M | $56M | $55M | $45M | $51M | $42M | $38M | $36M | $38M | $38M | $37M | $30M | $33M | $32M | $32M | $22M | |
| Net Income | $154M | $194M | $146M | $126M | $142M | $152M | $121M | $108M | $114M | $112M | $88M | $85M | $91M | $88M | $89M | $45M | |
| EPS (Basic) | $1.55 | $1.96 | $1.45 | $1.26 | $1.41 | $1.50 | $1.20 | $1.08 | $1.13 | $1.12 | $0.87 | $0.85 | $0.91 | $0.88 | $0.90 | $0.45 | |
| EPS (Diluted) | $1.54 | $1.93 | $1.43 | $1.24 | $1.39 | $1.48 | $1.18 | $1.06 | $1.12 | $1.10 | $0.86 | $0.84 | $0.90 | $0.87 | $0.89 | $0.45 | |
| Shares (Basic) | 98,800,000 | 99,200,000 | · | 100,500,000 | 100,600,000 | 100,500,000 | · | 99,900,000 | 99,900,000 | 99,800,000 | · | 99,500,000 | 99,500,000 | 99,400,000 | · | 99,200,000 | |
| Shares (Diluted) | 100,000,000 | 100,600,000 | · | 102,300,000 | 102,300,000 | 102,100,000 | · | 102,100,000 | 102,000,000 | 102,200,000 | · | 101,400,000 | 101,100,000 | 100,900,000 | · | 100,500,000 | |
| EBITDA | $90M | $87M | · | $82M | $80M | $79M | · | $78M | $73M | $70M | · | $67M | $73M | $64M | · | $62M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $108M | $110M | $72M | $49M | $99M | $96M | $85M | $148M | $154M | $134M | $69M | $100M | $118M | $85M | $22M | $60M | |
| Receivables | $687M | $676M | $613M | $611M | $612M | $623M | $593M | $576M | $590M | $619M | · | $536M | $532M | $514M | · | $500M | |
| Prepaid Expense | · | · | $54M | · | · | · | $42M | · | · | · | · | · | · | · | · | · | |
| Other Current Assets | $220M | $190M | $130M | $165M | $168M | $165M | $123M | $159M | $166M | $138M | · | $137M | $138M | $128M | · | $130M | |
| Current Assets | $1.04B | $1.03B | $906M | $870M | $918M | $911M | $887M | $934M | $938M | $930M | · | $814M | $824M | $762M | · | $734M | |
| Goodwill | $1.32B | $1.32B | $1.32B | $1.30B | $1.30B | $1.28B | $1.28B | $1.28B | $1.28B | $1.28B | $1.28B | $1.28B | $1.27B | $1.27B | $1.26B | $1.25B | |
| Intangibles | $307M | $300M | $308M | $292M | $296M | $294M | $298M | $296M | $303M | $272M | · | $276M | $278M | $287M | · | $285M | |
| Other Non-current Assets | $246M | $244M | $244M | $257M | $233M | $210M | $219M | $211M | $208M | $179M | · | $210M | $220M | $227M | · | $207M | |
| Total Assets | $7.46B | $7.31B | $7.09B | $6.87B | $6.79B | $6.64B | $6.53B | $6.46B | $6.39B | $6.23B | · | $5.96B | $5.86B | $5.75B | · | $5.48B | |
| Accounts Payable | $222M | $204M | $178M | $138M | $174M | $159M | $171M | $170M | $164M | $166M | · | $165M | $156M | $141M | · | $134M | |
| Accrued Liabilities | · | · | $55M | · | · | · | $31M | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $873M | $877M | $836M | $762M | $865M | $856M | $841M | $897M | $694M | $680M | · | $639M | $655M | $592M | · | $605M | |
| Capital Leases | $181M | $189M | $197M | $203M | $201M | $204M | $190M | $196M | $202M | $186M | · | $184M | $192M | $199M | · | $183M | |
| Deferred Tax | $132M | $135M | $127M | $108M | $111M | $114M | $105M | $97M | $91M | $94M | · | $80M | $83M | $87M | · | $47M | |
| Other Non-current Liabilities | $212M | $214M | $54M | $213M | $201M | $196M | $52M | $198M | $187M | $186M | · | $179M | $176M | $183M | · | $174M | |
| Total Liabilities | $4.00B | $3.95B | $3.81B | $3.68B | $3.70B | $3.70B | $3.69B | $3.73B | $3.86B | $3.83B | · | $3.78B | $3.80B | $3.78B | · | $3.73B | |
| Common Stock | · | · | $1M | · | · | · | $1M | · | · | · | · | · | · | · | · | · | |
| Paid-in Capital | · | · | $1.87B | · | · | · | $1.85B | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | · | · | $1.29B | · | · | · | $797M | · | · | · | · | · | · | · | · | · | |
| Treasury Stock | · | · | $722M | · | · | · | $578M | · | · | · | · | · | · | · | · | · | |
| AOCI | · | · | $500.0K | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $2.60B | $2.52B | $2.44B | $2.37B | $2.28B | $2.16B | $2.07B | $1.96B | $1.84B | $1.74B | · | $1.56B | $1.48B | $1.38B | · | $1.22B | |
| Liabilities + Equity | $7.46B | $7.31B | $7.09B | $6.87B | $6.79B | $6.64B | $6.53B | $6.46B | $6.39B | $6.23B | · | $5.96B | $5.86B | $5.75B | · | $5.48B | |
| Shares Outstanding | 98,800,000 | 99,400,000 | 100,000,000 | 100,700,000 | 100,900,000 | 100,900,000 | 100,800,000 | 100,800,000 | 100,700,000 | 100,700,000 | 100,300,000 | 100,200,000 | 100,200,000 | 100,200,000 | 99,800,000 | 99,800,000 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $90M | $87M | $86M | $82M | $80M | $79M | $78M | $78M | $73M | $70M | $70M | $67M | $73M | $64M | $63M | $62M | |
| Stock-based Comp | $14M | $12M | $18M | $14M | $14M | $10M | $12M | $13M | $14M | $9M | $13M | $14M | $16M | $8M | $8M | $5M | |
| Deferred Tax | $-3M | $8M | $19M | $-2M | $-4M | $9M | $9M | $-2M | $-2M | $6M | $7M | $-3M | $-4M | $4M | $36M | $200.0K | |
| Other Non-cash | · | $11M | · | · | · | $40M | · | · | · | $40M | · | · | · | $64M | · | · | |
| Operating Cash Flow | $283M | $313M | $346M | $271M | $270M | $289M | $279M | $268M | $217M | $239M | $201M | $215M | $207M | $228M | $172M | $70M | |
| CapEx | $220M | $162M | $229M | $187M | $157M | $163M | $199M | $148M | $157M | $139M | $212M | $158M | $125M | $100M | $209M | $145M | |
| Investing Cash Flow | $-236M | $-150M | $-239M | $-201M | $-165M | $-158M | $-204M | $-162M | $-158M | $-130M | $-208M | $-162M | $-128M | $-104M | $-206M | $-174M | |
| Stock Repurchased | $74M | $72M | $76M | $25M | $25M | $32M | $8M | $7M | $17M | $0 | $0 | $0 | · | · | · | · | |
| Net Stock Activity | · | $-72M | · | · | · | $-32M | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid | $19M | $20M | $19M | $17M | $17M | $18M | $17M | $15M | $15M | $16M | $15M | $15M | $15M | $16M | $15M | $28M | |
| Financing Cash Flow | $-77M | $-102M | $-97M | $-113M | $-90M | $-130M | $-151M | $-90M | $-50M | $-41M | $-30M | $-66M | $-44M | $-58M | $-16M | $-49M | |
| Net Change in Cash | $-30M | $60M | $9M | $-44M | $15M | $-300.0K | $-76M | $17M | $9M | $68M | $-37M | $-13M | $35M | $66M | $-51M | $-153M | |
| Free Cash Flow | · | $151M | · | · | · | $126M | · | · | · | $99M | · | · | · | $131M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $72M | · | · | · | $103M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | 9.6% | 12.3% | · | 8.6% | 9.8% | 10.4% | · | 8.0% | 8.8% | 8.6% | · | 7.1% | 7.7% | 7.6% | · | 4.2% | |
| Pretax Margin | 16.4% | 18.2% | · | 14.9% | 16.2% | 16.4% | · | 13.6% | 14.3% | 13.6% | · | 12.0% | 12.7% | 12.6% | · | 9.8% | |
| EBITDA Margin | 5.7% | 5.5% | · | 5.6% | 5.5% | 5.4% | · | 5.8% | 5.6% | 5.3% | · | 5.6% | 6.1% | 5.5% | · | 5.7% | |
| ROA | 2.2% | 2.8% | · | 1.9% | 2.2% | 2.4% | · | 1.7% | 1.9% | 1.9% | · | 1.5% | 1.4% | 1.4% | · | 0.74% | |
| ROE | 6.3% | 8.3% | · | 5.8% | 6.9% | 7.8% | · | 6.2% | 6.9% | 7.2% | · | 6.1% | 5.3% | 5.2% | · | 3.0% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | 1.2 | · | 1.1 | 1.1 | 1.1 | · | 1.0 | 1.4 | 1.4 | · | 1.3 | 1.3 | 1.3 | · | 1.2 | |
| Quick Ratio | 0.9 | 0.9 | · | 0.9 | 0.8 | 0.8 | · | 0.8 | 1.1 | 1.1 | · | 1.0 | 1.0 | 1.0 | · | 0.9 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Receivables Turnover | 2.5 | 2.4 | · | 2.5 | 2.4 | 2.3 | · | 2.4 | 2.3 | 2.3 | · | 2.3 | 2.0 | 1.9 | · | 1.9 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $26.29 | $25.37 | · | $23.57 | $22.60 | $21.40 | · | $19.44 | $18.27 | $17.30 | · | $15.57 | $14.72 | $13.81 | · | $12.19 | |
| Revenue / Share | $15.97 | $15.77 | · | $14.44 | $14.25 | $14.25 | · | $13.23 | $12.76 | $12.88 | · | $11.90 | $11.74 | $11.50 | · | $10.84 | |
| Cash Flow / Share | · | $3.11 | · | · | · | $2.83 | · | · | · | $2.34 | · | · | · | $2.26 | · | · | |
| Cash / Share | $1.09 | $1.11 | · | $0.48 | $0.98 | $0.95 | · | $1.47 | $1.53 | $1.33 | · | $0.99 | $1.17 | $0.85 | · | $0.60 | |
| Dividend / Share | $0.19 | $0.19 | $0.19 | $0.19 | $0.17 | $0.17 | $0.17 | $0.17 | $0.15 | $0.15 | $0.15 | $0.15 | $0.15 | $0.15 | $0.15 | $0.15 | |
| EPS (TTM) | $6.14 | $5.99 | · | $5.29 | $5.11 | $4.84 | · | $4.14 | $3.92 | $3.70 | · | $3.50 | $3.11 | $2.70 | · | $2.72 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $6.21B | $6.07B | · | $5.80B | $5.67B | $5.51B | · | $5.21B | $5.07B | $4.96B | · | $4.69B | $4.57B | $4.45B | · | $3.70B | |
| Net Income TTM | $621M | $609M | · | $541M | $523M | $495M | · | $422M | $400M | $377M | · | $354M | $314M | $271M | · | $273M | |
| Market Cap | $9.99B | $9.61B | · | $12.79B | $12.37B | $10.22B | · | $9.74B | $8.64B | $8.32B | · | $6.73B | $6.78B | $5.42B | · | $4.51B | |
| P/E | 16.5 | 16.1 | · | 24.0 | 24.0 | 20.9 | · | 23.3 | 21.9 | 22.3 | · | 19.2 | 21.8 | 20.0 | · | 16.6 | |
| P/S | 1.6 | 1.6 | · | 2.2 | 2.2 | 1.9 | · | 1.9 | 1.7 | 1.7 | · | 1.4 | 1.5 | 1.2 | · | 1.2 | |
| P/B | 3.8 | 3.8 | · | 5.4 | 5.4 | 4.7 | · | 5.0 | 4.7 | 4.8 | · | 4.3 | 4.6 | 3.9 | · | 3.7 | |
| P / Tangible Book | 10.3 | 10.6 | · | 16.4 | 18.2 | 17.6 | · | 25.7 | 34.2 | 44.1 | · | 2492.4 | · | · | · | · | |
| P / Cash Flow | · | 30.7 | · | · | · | 35.4 | · | · | · | 34.8 | · | · | · | 23.8 | · | · | |
| Dividend Yield | 0.75% | 0.76% | · | 0.54% | 0.54% | 0.64% | · | 0.62% | 0.70% | 0.73% | · | 0.90% | 1.1% | 1.6% | · | 2.5% | |
| Earnings Yield | 6.1% | 6.2% | · | 4.2% | 4.2% | 4.8% | · | 4.3% | 4.6% | 4.5% | · | 5.2% | 4.6% | 5.0% | · | 6.0% | |
| Payout Ratio | · | 10.4% | · | · | · | 11.9% | · | · | · | 14.1% | · | · | · | 17.8% | · | · | |
| Annual Payout | $75M | $73M | · | $69M | $67M | $65M | · | $61M | $61M | $61M | · | $60M | $73M | $86M | · | $112M |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $5.94B | $5.37B | $4.80B | $4.35B | $4.01B |
| Betriebsgewinnmarge % | · | · | · | 12.4% | · |
| Nettoergebnis | $566M | $456M | $352M | $271M | $412M |
| Verwässerte EPS | $5.54 | $4.46 | $3.47 | $2.70 | $4.11 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 1.1 | 1.1 | 1.3 | 1.2 | 1.2 |
| Quick Ratio | 0.8 | 0.8 | 1.0 | 0.9 | 1.0 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $439M | $360M | $268M | $141M | $187M |
Institutionelle Eigentümer (13F) 647 Einreicher · $10.0B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
647
Gehaltener Wert
$10.0B
Neue Positionen
72
Geschlossene Positionen
37
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 72 (-13 vs. Vorquartal) | 37 (-42 vs. Vorquartal) | 220 (-10 vs. Vorquartal) | 219 (+32 vs. Vorquartal) | +2.0M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $1.075.201.277 | 10.130.029 | 10,79% | Aktien |
| BlackRock, Inc. | $1.059.761.675 | 10.484.385 | 10,63% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $497.785.037 | 4.924.664 | 4,99% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $452.423.568 | 4.475.896 | 4,54% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $331.414.937 | 3.278.739 | 3,33% | Aktien |
| STATE STREET CORP | $322.020.462 | 3.185.798 | 3,23% | Aktien |
| CITADEL ADVISORS LLC | $259.078.552 | 2.563.104 | 2,60% | Aktien |
| FULLER & THALER ASSET MANAGEMENT, INC. | $248.723.177 | 2.460.657 | 2,50% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $239.092.474 | 2.471.751 | 2,40% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $229.215.881 | 2.267.668 | 2,30% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $191.163.529 | 1.890.743 | 1,92% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $176.185.032 | 1.743.028 | 1,77% | Aktien |
| GOLDMAN SACHS GROUP INC | $156.754.618 | 1.550.797 | 1,57% | Aktien |
| Invesco Ltd. | $117.364.796 | 1.161.108 | 1,18% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $116.942.484 | 1.156.930 | 1,17% | Aktien |
| NORGES BANK | $116.733.653 | 1.154.864 | 1,17% | Aktien |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $116.351.672 | 1.151.085 | 1,17% | Aktien |
| MORGAN STANLEY | $115.926.200 | 1.146.873 | 1,16% | Aktien |
| JPMORGAN CHASE & CO | $114.840.512 | 1.133.561 | 1,15% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $107.572.603 | 1.064.233 | 1,08% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $106.181.901 | 1.050.470 | 1,07% | Aktien |
| Eversept Partners, LP | $103.800.973 | 1.026.919 | 1,04% | Aktien |
| BROWN ADVISORY INC | $102.366.881 | 1.012.731 | 1,03% | Aktien |
| Holocene Advisors, LP | $98.819.245 | 977.634 | 0,99% | Aktien |
| NORTHERN TRUST CORP | $98.116.739 | 970.684 | 0,98% | Aktien |
| Sumitomo Mitsui Trust Group, Inc. | $94.037.756 | 930.330 | 0,94% | Aktien |
| Capital Research Global Investors | $88.196.343 | 872.540 | 0,88% | Aktien |
| Copeland Capital Management, LLC | $86.465.426 | 855.415 | 0,87% | Aktien |
| Bank of New York Mellon Corp | $81.676.122 | 808.034 | 0,82% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $81.441.874 | 805.717 | 0,82% | Aktien |
| BANK OF AMERICA CORP /DE/ | $79.660.158 | 788.090 | 0,80% | Aktien |
| Allianz Asset Management GmbH | $70.954.117 | 701.960 | 0,71% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $69.569.725 | 688.264 | 0,70% | Aktien |
| AMERIPRISE FINANCIAL INC | $64.412.004 | 637.218 | 0,65% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $63.453.374 | 627.754 | 0,64% | Aktien |
| JENNISON ASSOCIATES LLC | $61.331.503 | 606.762 | 0,62% | Aktien |
| FRANKLIN RESOURCES INC | $60.494.863 | 598.485 | 0,61% | Aktien |
| JANE STREET GROUP, LLC | $58.888.804 | 582.596 | 0,59% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $56.576.495 | 561.888 | 0,57% | Aktien |
| Qube Research & Technologies Ltd | $56.391.016 | 557.885 | 0,57% | Aktien |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $55.475.233 | 548.825 | 0,56% | Aktien |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $44.796.000 | 443.177 | 0,45% | Aktien |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | $44.792.698 | 443.140 | 0,45% | Aktien |
| REINHART PARTNERS, LLC. | $44.008.230 | 435.362 | 0,44% | Aktien |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $43.276.391 | 428.140 | 0,43% | Aktien |
| SEI INVESTMENTS CO | $41.745.070 | 412.994 | 0,42% | Aktien |
| CONGRESS ASSET MANAGEMENT CO | $41.050.742 | 406.121 | 0,41% | Aktien |
| VICTORY CAPITAL MANAGEMENT INC | $39.864.840 | 394.389 | 0,40% | Aktien |
| D. E. Shaw & Co., Inc. | $38.874.863 | 384.595 | 0,39% | Aktien |
| Freestone Grove Partners LP | $38.677.251 | 382.640 | 0,39% | Aktien |
Aktivisten & 5%+-Eigentümer 2 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| East Peak Partners, L.P., JGE Capital Management, LLC, Jeffrey G. Edwards ×2 Einreichungen | 10. Juni 2008 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 12. Mai 2005 | · | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 51 Insider · 20 Führungskräfte · 25 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| April Kaye Bullock Anthony | CEO & President, Home Health | 18. Juni 2021 D | 175.269 | 0 | 0 | $0 |
| Jay Grinney | Pres & Chief Executive Officer | 31. Dezember 2016 D | 1.231.767 | 0 | 0 | $0 |
| Diane L Munson | President, OP Services | 31. Juli 2007 D | 5.772 | 0 | 0 | $0 |
| Joseph T Clark | President, Surgery Division | 30. Juni 2007 D | 1.569 | 0 | 0 | $0 |
| Gregory R Brophy | President, Diagnostic Division | 2. März 2007 A | 12.000 | 0 | 0 | $0 |
| Keren G Davis | President, Diagnostic Division | 23. Februar 2006 A | 30.898 | 0 | 0 | $0 |
| Patrick A Foster | President and COO Inpatient | 20. Mai 2004 F | 83.150 | 0 | 0 | $0 |
| Larry D Taylor | President and COO, Surgery | 5. März 2004 A | 73.700 | 0 | 0 | $0 |
| Patrick William Tuer | EVP, Chief Operating Officer | 11. Mai 2026 S | 24.755 | 0 | 2 | $-373.076 |
| Michael D Snow | Chief Operating Officer | 30. Juni 2007 D | 17.548 | 0 | 0 | $0 |
| John Patrick Darby | EVP, Gen Counsel & Secretary | 31. August 2026 M | 75.041 | 0 | 2 | $-1.709.966 |
| Andrew L Price | Chief Accounting Officer | 31. August 2026 S | 69.483 | 0 | 1 | $-630.166 |
| Edmund Fay | Sr. Vice Pres. and Treasurer | 9. März 2026 G | 86.325 | 0 | 1 | $-1.277.259 |
| Elissa Joy Charbonneau | Chief Medical Officer | 28. Februar 2026 F | 17.644 | 0 | 0 | $0 |
| Cheryl B. Levy | Chief Human Resources Officer | 25. Februar 2019 F | 41.732 | 0 | 0 | $0 |
| John P Whittington | EVP, Gen. Counsel & Secretary | 18. Februar 2016 A | 202.094 | 0 | 0 | $0 |
| Dexanne B Clohan | Chief Medical Officer | 31. Juli 2015 M | 109.120 | 0 | 0 | $0 |
| John F Markus | Chief Compliance Officer | 4. August 2007 D | 5.942 | 0 | 0 | $0 |
| Gregory L Doody | Exec VP Legal and Secretary | 31. Juli 2006 D | 0 | 0 | 0 | $0 |
| James C Foxworthy | Chief Administrative Officer | 23. Februar 2006 A | 144.418 | 0 | 0 | $0 |
| Edward M Christie III | Direktor | 16. Juli 2026 A | 9.345 | 0 | 0 | $0 |
| Christopher R Reidy | Direktor | 16. Juli 2026 A | 17.777 | 0 | 0 | $0 |
| Cain A Hayes | Direktor | 15. Juli 2026 A | 2.096 | 0 | 0 | $0 |
| Kevin J. O'Connor | Direktor | 15. Juli 2026 A | 11.582 | 0 | 0 | $0 |
| Terrance Williams | Direktor | 15. Juli 2026 A | 16.859 | 0 | 0 | $0 |
| Nancy M Schlichting | Direktor | 15. Juli 2026 A | 22.972 | 0 | 0 | $0 |
| Joan E Herman | Direktor | 15. Juli 2026 A | 49.643 | 0 | 0 | $0 |
| Greg D Carmichael | Direktor | 15. Juli 2026 A | 20.349 | 0 | 0 | $0 |
| Leslye G Katz | Direktor | 15. Juli 2026 A | 49.643 | 0 | 0 | $0 |
| Patricia Anne Maryland | Direktor | 15. Juli 2025 A | 14.764 | 0 | 0 | $0 |
| John Chidsey | Direktor | 16. April 2024 A | 162.826 | 0 | 0 | $0 |
| Donald L Correll | Direktor | 15. April 2024 A | 99.938 | 0 | 0 | $0 |
| John E Jr D D S Maupin | Direktor | 19. April 2022 A | 81.262 | 0 | 0 | $0 |
| Edward L Shaw JR | Direktor | 19. April 2022 A | 99.385 | 0 | 0 | $0 |
| Yvonne M Curl | Direktor | 18. April 2022 A | 78.458 | 0 | 0 | $0 |
| Charles M Elson | Direktor | 18. April 2022 A | 82.981 | 0 | 0 | $0 |
| HIGDON LEO I JR | Direktor | 18. April 2022 A | 5.104 | 0 | 0 | $0 |
| Jon F Hanson | Direktor | 16. April 2014 A | 88.770 | 0 | 0 | $0 |
| Edward A Blechschmidt | Direktor | 11. April 2012 J | 52.844 | 0 | 0 | $0 |
| BERRARD STEVEN R | Direktor | 18. Mai 2006 D | 24.973 | 0 | 0 | $0 |
| Robert P May | Direktor | 20. Oktober 2005 D | 23.531 | 0 | 0 | $0 |
| George H Strong | Direktor | 29. Januar 2004 P | 89.217 | 0 | 0 | $0 |
| John S Chamberlin | Direktor | 20. Januar 2004 A | 140.432 | 0 | 0 | $0 |
| Larry D Striplin JR | Direktor | 20. Januar 2004 A | 73.432 | 0 | 0 | $0 |
| Mark J Tarr | · | 10. August 2026 S | 267.814 | 0 | 9 | $-38.470.785 |
| Douglas E Coltharp | · | 10. August 2026 S | 50.508 | 0 | 3 | $-5.324.345 |
| Barbara Ann Jacobsmeyer | · | 1. März 2022 A | 59.539 | 0 | 0 | $0 |
| John L Workman | · | 17. November 2009 D | 72.716 | 0 | 0 | $0 |
| Joel C Gordon | · | 10. Mai 2005 D | 1.348.023 | 0 | 0 | $0 |
| Lee S Hillman | · | 18. Februar 2005 D | 2.024 | 0 | 0 | $0 |
| Sage C Givens | · | 20. Januar 2004 A | 41.432 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 75 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| OSCV · ETF Series Solutions | 2,13% | 135.598 NS | 31. Juli 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 1,86% | 175.295 NS | 31. Juli 2026 | N-PORT |
| IHF · iShares Trust | 1,76% | 190.583 SH | 11. September 2026 | Täglich |
| GRPM · Invesco Exchange-Traded Fund Trust | 1,44% | 58.324 SH | 1. Oktober 2026 | Täglich |
| XMLV · Invesco Exchange-Traded Fund Trust … | 1,05% | 59.115 SH | 1. Oktober 2026 | Täglich |
| HSMV · First Trust Exchange-Traded Fund III | 1,02% | 3.221 NS | 31. Juli 2026 | N-PORT |
| SMDX · Tidal Trust III | 0,69% | 8.093 NS | 31. Juli 2026 | N-PORT |
| CZA · Invesco Exchange-Traded Fund Trust | 0,62% | 8.655 SH | 1. Oktober 2026 | Täglich |
| RFG · Invesco Exchange-Traded Fund Trust | 0,60% | 16.279 SH | 1. Oktober 2026 | Täglich |
| IVOG · VANGUARD ADMIRAL FUNDS | 0,52% | 97.881 SH | 19. August 2026 | Täglich |
| QLV · FlexShares Trust | 0,49% | 7.224 NS | 31. Juli 2026 | N-PORT |
| VFMV · VANGUARD WELLINGTON FUND | 0,46% | 18.863 SH | 19. August 2026 | Täglich |
| IQSM · New York Life Investments ETF Trust | 0,42% | 12.521 NS | 31. Juli 2026 | N-PORT |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0,39% | 13.067 SH | 1. Oktober 2026 | Täglich |
| FNY · First Trust Exchange-Traded AlphaDE… | 0,35% | 18.161 NS | 31. Juli 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,33% | 13.621 NS | 31. Juli 2026 | N-PORT |
| PTMC · Pacer Funds Trust | 0,31% | 10.882 NS | 31. Juli 2026 | N-PORT |
| IVOO · VANGUARD ADMIRAL FUNDS | 0,27% | 160.356 SH | 19. August 2026 | Täglich |
| BKMC · BNY Mellon ETF Trust | 0,26% | 15.377 NS | 31. Juli 2026 | N-PORT |
| RWK · Invesco Exchange-Traded Fund Trust … | 0,26% | 26.726 SH | 1. Oktober 2026 | Täglich |
| ESML · iShares Trust | 0,25% | 58.197 SH | 11. September 2026 | Täglich |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,24% | 9.827 NS | 31. Juli 2026 | N-PORT |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,24% | 43.342 NS | 31. Juli 2026 | N-PORT |
| MIDU · Direxion Shares ETF Trust | 0,24% | 1.456 NS | 31. Juli 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,23% | 52.547 NS | 31. Juli 2026 | N-PORT |
| ISCG · iShares Trust | 0,22% | 17.302 SH | 11. September 2026 | Täglich |
| VBR · VANGUARD INDEX FUNDS | 0,21% | 1.444.357 SH | 19. August 2026 | Täglich |
| IYH · iShares Trust | 0,19% | 57.739 SH | 11. September 2026 | Täglich |
| SMMD · iShares Trust | 0,17% | 52.551 SH | 11. September 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,16% | 226.407 NS | 31. Juli 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,16% | 47.198 NS | 31. Juli 2026 | N-PORT |
| NFRA · FlexShares Trust | 0,15% | 41.445 NS | 31. Juli 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,15% | 298.871 SH | 19. August 2026 | Täglich |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0,14% | 10.513 NS | 31. Juli 2026 | N-PORT |
| ESUM · Strategy Shares | 0,14% | 2.294 NS | 31. Juli 2026 | N-PORT |
| VB · VANGUARD INDEX FUNDS | 0,12% | 2.275.030 SH | 19. August 2026 | Täglich |
| IWS · iShares Trust | 0,12% | 147.557 SH | 11. September 2026 | Täglich |
| FTLS · First Trust Exchange-Traded Fund III | 0,12% | 25.879 NS | 31. Juli 2026 | N-PORT |
| WSML · iShares Trust | 0,11% | 6.185 SH | 11. September 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,11% | 1.138.311 SH | 19. August 2026 | Täglich |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,10% | 5.455 NS | 31. Juli 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,10% | 6.234 SH | 1. Oktober 2026 | Täglich |
| IWR · iShares Trust | 0,09% | 404.246 SH | 11. September 2026 | Täglich |
| DXUV · Dimensional ETF Trust | 0,08% | 4.083 NS | 31. Juli 2026 | N-PORT |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,08% | 10.190 NS | 31. Juli 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0,06% | 82.039 NS | 31. Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,05% | 213.642 NS | 31. Juli 2026 | N-PORT |
| JMOM · J.P. Morgan Exchange-Traded Fund Tr… | 0,04% | 9.905 NS | 31. Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,04% | 12.046 NS | 31. Juli 2026 | N-PORT |
| IUSG · iShares Trust | 0,03% | 87.340 SH | 11. September 2026 | Täglich |
| IWD · iShares Trust | 0,03% | 218.350 SH | 11. September 2026 | Täglich |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,03% | 2.522 SH | 1. Oktober 2026 | Täglich |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,03% | 59.361 SH | 19. August 2026 | Täglich |
| DFAU · Dimensional ETF Trust | 0,02% | 25.298 NS | 31. Juli 2026 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,02% | 7.846 SH | 1. Oktober 2026 | Täglich |
| ESGV · VANGUARD WORLD FUND | 0,02% | 22.240 SH | 19. August 2026 | Täglich |
| TILT · FlexShares Trust | 0,02% | 3.402 NS | 31. Juli 2026 | N-PORT |
| IYY · iShares Trust | 0,02% | 4.296 SH | 10. September 2026 | Täglich |
| IWB · iShares Trust | 0,02% | 68.163 SH | 11. September 2026 | Täglich |
| IWV · iShares Trust | 0,02% | 27.979 SH | 10. September 2026 | Täglich |
| PRF · Invesco Exchange-Traded Fund Trust | 0,02% | 13.574 SH | 1. Oktober 2026 | Täglich |
| DFUS · Dimensional ETF Trust | 0,02% | 31.574 NS | 31. Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,02% | 130.529 SH | 11. September 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 3.151.418 SH | 19. August 2026 | Täglich |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 78.793 SH | 19. August 2026 | Täglich |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,01% | 16.144 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 8.257 SH | 19. August 2026 | Täglich |
| NEAR · iShares U.S. ETF Trust | 0,00% | 83.000 SH | 9. September 2026 | Täglich |
| IJH · iShares Trust | · | 3.481.076 SH | 11. September 2026 | Täglich |
| IJK · iShares Trust | · | 574.423 SH | 11. September 2026 | Täglich |
| XJH · iShares Trust | · | 13.552 SH | 8. September 2026 | Täglich |
| ISCB · iShares Trust | · | 4.462 SH | 11. September 2026 | Täglich |
| ISCV · iShares Trust | · | 9.814 SH | 11. September 2026 | Täglich |
| SMLF · iShares Trust | · | 41.132 SH | 11. September 2026 | Täglich |
| SMMV · iShares Trust | · | 19.246 SH | 26. August 2026 | Täglich |
EHC Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 18 Analysten
KAUF
Median-Ziel
$150.00
+25,2%
7 38,9%
Starker Kauf
10 55,6%
Kauf
1 5,6%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
12 Analysten · 2026-09-27Mittelwert-Ziel $148.17 +23,7%
← Unter allen Zielen
Aktueller Preis $119.80
Tief$140.00
Mittelwert$148.17
Hoch$155.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| EHC | $10.61B | 19.2 | 10.5% | 9.5% | 25.1% | · |
| HCA | $104.86B | 16.5 | 7.1% | 9.0% | -159.1% | · |
| THC | $17.28B | 12.8 | 3.1% | 11.1% | 56.4% | · |
| UHS | · | 9.4 | 9.7% | 8.6% | 21.4% | · |
| ENSG | $10.12B | 29.8 | 18.7% | 6.8% | 16.9% | · |
| PACS | $6.01B | 31.5 | 29.3% | 3.6% | 23.1% | · |
| CON | $2.53B | 15.1 | 13.9% | 7.7% | 49.8% | · |
| BKD | $2.57B | -9.6 | 2.2% | -8.2% | -313.2% | 26.2% |
| ACHC | $1.28B | -1.2 | 5.0% | -33.3% | -43.9% | · |
| SNDA | $612M | -7.7 | 25.2% | -18.6% | -197.2% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 7, 2026